CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 136 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 12.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,000 | +266.7% | 1,700 | +325.0% | 0.00% | – |
| Q2 2020 | $3,000 | -57.1% | 400 | -34.5% | 0.00% | – |
| Q2 2019 | $7,000 | +600.0% | 611 | +748.6% | 0.00% | – |
| Q3 2018 | $1,000 | -99.6% | 72 | -99.3% | 0.00% | -100.0% |
| Q2 2018 | $239,000 | +602.9% | 10,457 | +769.2% | 0.02% | +650.0% |
| Q1 2018 | $34,000 | +325.0% | 1,203 | +200.0% | 0.00% | +100.0% |
| Q4 2017 | $8,000 | +60.0% | 401 | +33.7% | 0.00% | – |
| Q2 2017 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |